GSA Capital Partners’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,385
| Closed | -$242K | – | 2145 |
|
|
2024
Q4 | $242K | Sell |
8,385
-1,972
| -19% | -$56.9K | 0.02% | 1327 |
|
|
2024
Q3 | $246K | Buy |
+10,357
| New | +$246K | 0.02% | 1327 |
|
|
2023
Q2 | – | Sell |
-5,726
| Closed | -$98K | – | 2006 |
|
|
2023
Q1 | $98K | Sell |
5,726
-24,916
| -81% | -$426K | 0.01% | 1363 |
|
|
2022
Q4 | $712K | Buy |
30,642
+3,399
| +12% | +$79K | 0.09% | 393 |
|
|
2022
Q3 | $605K | Buy |
27,243
+12,621
| +86% | +$280K | 0.08% | 439 |
|
|
2022
Q2 | $281K | Buy |
+14,622
| New | +$281K | 0.04% | 866 |
|